Global buyout giant KKR has closed KKR Health Care Strategic Growth Fund II on $4bn, just shy of tripling the size of its $1.45bn predecessor fund I which was closed in 2017.
KKR has made $18bn of investments in the health care industry since 2004, including buying into Argenta, Nordic Bioscience, Sapphiros, Geode Health, and Cordis last year.
The firm has also pulled in $16.8bn for its mammoth new North America Fund XIII fundraise in November and closed its third US-focused opportunistic real estate fund on $4.3bn in October.
Read more/Source: Alt Assets
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.